Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine.
about
Interventions for the control of diarrhoeal diseases among young children: rotavirus and cholera immunizationCholera toxin genes: nucleotide sequence, deletion analysis and vaccine developmentInapparent infections and cholera dynamics.Oral vaccines against cholera.CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain.Use of in vivo-induced antigen technology (IVIAT) to identify genes uniquely expressed during human infection with Vibrio choleraeImmunogenicity of Vibrio cholerae O1 toxin-coregulated pili in experimental and clinical cholera.Molecular basis of cholera blood-group dependence and implications for a world characterized by climate change.Maximizing protection from use of oral cholera vaccines in developing country settings: an immunological review of oral cholera vaccines.Vibrio cholerae-induced inflammation in the neonatal mouse cholera modelMonoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxin-induced chloride secretory response and block toxin binding to intestinal epithelial cells in vitroNew knowledge on pathogenesis of bacterial enteric infections as applied to vaccine developmentAntitoxic immunity to cholera in dogs immunized orally with cholera toxin.Simple, direct conjugation of bacterial O-SP-core antigens to proteins: development of cholera conjugate vaccines.Preparation of a purified antigenic cholera toxoidSimple method for purifying choleragenoid, the natural toxoid of Vibrio cholerae.Induction of a mucosal antitoxin response and its role in immunity to experimental canine choleraVibrio cholerae: lessons for mucosal vaccine design.A De in the life of choleraHuman immune response to Vibrio cholerae O1 whole cells and isolated outer membrane antigens.Vibrio cholerae O1 infection induces proinflammatory CD4+ T-cell responses in blood and intestinal mucosa of infected humans.Isolation of enterotoxin structural gene deletion mutations in Vibrio cholerae induced by two mutagenic vibriophages.Effect of chemical and heat inactivation on the antigenicity and immunogenicity of Vibrio cholerae.Antibacterial and antitoxin responses in the serum and milk of cholera patients.The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139.Live attenuated oral cholera vaccines.Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin.Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21aDeterminants of immunogenicity and mechanisms of protection by virulent and mutant Vibrio cholerae O1 in rabbits.Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques.Determinants of the immunogenicity of live virulent and mutant Vibrio cholerae O1 in rabbit intestine.Cell-associated hemagglutinin-deficient mutant of Vibrio choleraeProtective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin.Effect of subgingival scaling on systemic antibody responses to oral microorganismsCompared colonizing and immunizing efficiency of toxinogenic (A+ B+) Vibrio cholerae and an A- B+ mutant (Texas Star-SR) studied in adult rabbitsEvaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccineSuccessful colonization and immunization of adult rabbits by oral inoculation with Vibrio cholerae O1.Comparison of clinical features and immunological parameters of patients with dehydrating diarrhoea infected with Inaba or Ogawa serotypes of Vibrio cholerae O1.Development of an enzyme-linked immunosorbent assay for studying Vibrio cholerae cell surface antigens.Selection and characteristics of a Vibrio cholerae mutant lacking the A (ADP-ribosylating) portion of the cholera enterotoxin.
P2860
Q24651074-552E9B66-8175-4F72-ACEB-449B9A955244Q28485732-F9D61179-2A0E-4426-A454-A1D51832659DQ30371386-A685812F-3548-4A8C-AF0B-1E014120C00AQ30401927-E212C08E-4954-407C-83FD-20E1C497D048Q30422416-C780039D-492C-473D-9DDF-80FC504ACBF3Q31147722-E8267D41-96B7-4479-9E7E-CA8BD7A2088BQ33263833-AF47B859-D31D-45F1-BBC8-A52322906266Q33563620-A6D6E7A7-4C3C-4E3A-8020-54519D964F20Q33578033-9E163C5C-6821-41C8-885B-E9EDA0D31F06Q33602997-8DE57432-4BD1-4FBB-B626-B392722C8FD2Q33617401-0A20E4ED-7D90-4F8E-981C-ECA522D5301FQ33628356-35B09476-AFC3-4580-803D-57E5F1C00DE9Q33899855-18B1E330-5769-4C1A-B117-0BBCC8B54C0DQ34214205-A3324273-F7B3-4A2A-9960-4BAA1CD2CA64Q34397962-531406C8-D71C-41A8-A61A-10DF7ED8080BQ34408958-1258248F-E196-4808-9646-5FCAE5C6E93AQ34450456-67BC39FF-02D3-40F2-8A20-B7ACEC1BB155Q34562952-B201136B-30E7-475E-8D57-A002609B2474Q34943171-A5B14063-C84C-4FB3-AF19-E8AEB14D85B1Q35090620-A81DD276-A15C-4C14-B498-44C3AD620C26Q35138715-DB87FE9F-F870-4375-9A52-6DC192EBE6ACQ36275022-D3EFE474-3B7C-43B1-8EF3-297F8E948C8FQ36334594-966DFB71-A6A3-46CA-90A8-4A6126734A97Q36421602-185DB6D0-9C48-48CB-8E41-5B181616B8ADQ36445329-969E10CD-16BD-4D41-A3FD-19C13B7A8BDDQ36600341-D57B99E8-9D5A-423C-94E2-DA0053F8E559Q36949262-1A1EF3A8-741C-4C6E-89D1-84131160A475Q36982528-92F3E9E0-809F-4A25-8954-E4E1E3F44EFFQ36992532-F06AAD0C-5403-49B1-8D99-4A12DF661001Q36992602-BBAC0DD5-0BBF-4016-AC32-E60BAD1DCFE2Q37016640-A30C0F45-270E-4593-9445-38495339F6B0Q37017821-F62D4589-FC9F-4DEB-8A6A-7A3791C8E080Q37018216-1760C195-6521-456F-881D-E43993526D36Q37036581-376E6C71-A6D1-40B4-8F95-72B416014C8DQ37082399-82C9E1D2-13BD-4388-ADF1-76996F54524FQ37098602-7C8AA46E-3986-45A9-95F3-C135E209C310Q37107796-E5C4FB9A-719F-4B51-AD62-70577AAD220FQ37206031-45BDBB45-B995-4264-B659-64A5BA114BE9Q37294854-6883FB3F-273D-47E7-A4E1-60E73304C014Q37329020-97EC4FC0-4979-4E3C-92A3-34955EE7957F
P2860
Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine.
description
1974 nî lūn-bûn
@nan
1974 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1974 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1974年の論文
@ja
1974年論文
@yue
1974年論文
@zh-hant
1974年論文
@zh-hk
1974年論文
@zh-mo
1974年論文
@zh-tw
1974年论文
@wuu
name
Response of man to infection w ...... previous disease and vaccine.
@ast
Response of man to infection w ...... previous disease and vaccine.
@en
type
label
Response of man to infection w ...... previous disease and vaccine.
@ast
Response of man to infection w ...... previous disease and vaccine.
@en
prefLabel
Response of man to infection w ...... previous disease and vaccine.
@ast
Response of man to infection w ...... previous disease and vaccine.
@en
P2093
P356
P1476
Response of man to infection w ...... previous disease and vaccine.
@en
P2093
P304
P356
10.1093/INFDIS/130.4.325
P407
P577
1974-10-01T00:00:00Z